Earth Capital is excited to be working with Dalgety, a UK-licensed medical cannabis cultivation and manufacturing facility. Dalgety’s state-of-the-art, 30,000 sq ft facility is setting new benchmarks for quality, security and innovation. Recently featured in The Times, The Express, BBC News, The Mirror and The Daily Mail, Dalgety is leading the way in medical cannabis production and innovation. A recent BBC News TV feature provided an exclusive look inside Dalgety’s high-security operations, highlighting its impact on the UK’s medical cannabis industry (Watch the video here).
Cutting-Edge Cultivation and Innovation
Dalgety’s facility, fully licensed by the Home Office and MHRA, is a significant step for the UK’s medical cannabis industry. According to The Times, Dalgety produces an impressive 40 kilograms of pharmaceutical-grade cannabis flowers each month, supporting 4,000 prescriptions.
Meanwhile, BBC News showcased how Dalgety’s AI-driven climate control systems regulate THC, CBD, and other cannabinoid levels, ensuring consistency and pharmaceutical-grade quality. Each strain undergoes meticulous quality control tests to maintain the highest standards.
Unmatched Security and Compliance
Security is another cornerstone of Dalgety’s success. Featured in The Express, its high-security facility boasts bulletproof doors, round-the-clock surveillance by ex-military personnel and 150 CCTV cameras, ensuring the protection of its valuable operations. Its undisclosed location adds an extra layer of security, safeguarding its mission to provide safe and effective medical cannabis treatments.
Bridging the Gap in Medical Cannabis Access
Since the legalisation of medical cannabis in 2018, demand has surged. However, access through the NHS remains limited, leaving many patients reliant on private prescriptions. The Mirror highlighted how Dalgety is stepping up to bridge this gap, offering a reliable UK-grown supply to reduce dependence on imports and make treatment more accessible.
Additionally, The Express reported in 2023 alone, 360,000 medical cannabis prescriptions were issued – more than double the previous year. Dalgety’s expansion into cannabis oil production, a key component in NHS treatments, further cements its role as a leader in the UK’s medical cannabis sector.
Scaling Up for the Future
CEO James Leavesley, who transitioned from the energy sector, is on a mission to reshape public perceptions of medical cannabis. As reported by The Daily Mail, Dalgety is seeking £8 million in investment to expand its cultivation capacity fivefold, significantly increasing production and revenue.
Earth Capital: Supporting Growth and Innovation
As advisors, Earth Capital is supporting Dalgety in securing funding by connecting them with the most relevant investors to fuel their continued growth. By working closely with Dalgety’s leadership, Earth Capital ensures the strategy aligns with the company’s long-term growth and expansion plans.
With recognition from major publications and a dedication to quality, security and patient care, Dalgety is setting the standard for medical cannabis in the UK. Together with Earth Capital, the company is paving the way for better access to life-changing treatments.
References:
- BBC News – Inside the UK’s First Fully Licensed Medical Cannabis Facility
- BBC News TV – Video
- The Times – Bulletproof Doors and a Pungent Whiff: Inside the UK’s First Medical Cannabis Farm
- The Express – UK’s Largest Legal Medical Cannabis Factory Revealed
- The Mirror – Inside the UK’s Legal Medicinal Cannabis Factory
- The Daily Mail – Legal Cannabis Factory with Razor-Wire Security
